Marcaine Spinal Heavy

Bupivacaine Hydrochloride, the active ingredient in Marcaine Spinal Heavy, is a local anesthetic (amide type) presented as an injectable solution for infiltration use. It provides regional anesthesia for surgical procedures and pain management in adult patients.

GNH USA supplies Marcaine Spinal Heavy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Bupivacaine Hydrochloride is a long‑acting amide local anesthetic used for regional anesthesia.

Spinal anesthesia: produces dense sensory and motor block for surgeries below the umbilicus. Epidural anesthesia: enables continuous analgesia during labor or postoperative pain control. Peripheral nerve block: creates targeted numbness for limb surgeries.

Bupivacaine Hydrochloride may cause a range of adverse reactions following administration.

Common Side Effects: - Hypotension: reduced blood pressure due to sympathetic blockade. - Bradycardia: slowed heart rate, especially with high spinal levels. - Nausea and vomiting: gastrointestinal upset after block. - Dizziness or light‑headedness. - Pruritus: itching, often at the injection site. - Urinary retention: difficulty voiding.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances. - Seizures: central nervous system toxicity at high plasma concentrations. - Respiratory depression: inadequate ventilation due to central effects. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Allergic reaction: rash, bronchospasm, or anaphylaxis. - Persistent neurologic deficit: prolonged numbness or motor weakness.

When using Marcaine Spinal Heavy, clinicians should observe several safety measures. - Patient assessment: evaluate cardiovascular status and existing comorbidities before administration. - Dose selection: employ the lowest effective dose to achieve the desired block. - Monitoring: continuously observe for signs of systemic toxicity, especially during high spinal blocks. - Contraindications: avoid in patients with known hypersensitivity to amide‑type local anesthetics. - Pregnancy considerations: use only when benefits outweigh potential risks, as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Bupivacaine Hydrochloride can interact with other medications, affecting safety and efficacy.

Major Interactions (Avoid): - Other local anesthetics: additive risk of systemic toxicity. - Class I antiarrhythmics (e.g., quinidine, procainamide): may potentiate cardiotoxic effects. - Beta‑adrenergic blockers: can mask early signs of toxicity.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may increase plasma concentrations. - Concurrent lidocaine infusion: additive nerve block effect. - General anesthetics (e.g., propofol): may enhance hypotensive response.